Artificial intelligence based implantable drug delivery system

A system comprising an implantable device having from 3 mm to 6 mm diameter tubular form, wherein the implantable device is inserted subcutaneously and non-surgically by an injector device in a human body via an incision;

• the implantable device comprising a casing comprising a pump, a piston, a drug chamber comprising a drug, and an opening for release of the drug from the implantable device into a body of a subject;
• wherein the implantable device is configured to be located in a subcutaneous region within the body of the subject during delivery of the drug into the body of the subject;
• wherein the implantable device is configured to deliver multiple doses of the drug within the body of the subject with a dose-to-dose variation of ±25% or less by volume;
• and wherein the implantable device further comprises power supply and electronics;
• and wherein the implantable device is configured to notify the subject in case of failure of the implantable device.

A system comprising a software implemented module and an implantable device comprising:

• A. a casin that is substantially tubular and has at least a first end and a second end opposite to the first end,
• B. a semi-permeable membrane plug at or near the first end,
• C. a first chamber comprising an osmotic agent, wherein one wall of the first chamber comprises the semi-permeable plug,
• D. a second chamber comprising a drug,
• E. a third chamber comprising a flow switch and at least one drug delivery orifice,
• F. a piston separating the first chamber and the second chamber,
• G. a fourth chamber comprising an electronic control unit and a source of energy, and
• H. one or more sensors to detect amount of the drug released from the implantable device;
• wherein an osmotic pressure is configured to be built on ingress of a liquid into the first chamber through the semi-permeable membrane plug that displaces the piston towards the second chamber, which further pushes the drug present in the second chamber to be release from the at least one drug orifice, and
• wherein one or more sensors interact with the software implemented module to control the flow of the drug released from the implantable device.